Search

everythinglearnresearchcommunity

for

Search:↓

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Estrogen and androgenic hair increase melanoma risk, especially in European-ancestry individuals.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

New alopecia treatments aim for better results and fewer side effects.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Iron and zinc deficiencies may be treated to help female hair loss.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

New nanofiber technology improves wound healing by supporting cell growth and delivering treatments directly to the wound.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Scalp hair sweating is a significant predictor of hair cortisol levels.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Upadacitinib may effectively treat alopecia areata without side effects.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Low testosterone levels may contribute to female pattern hair loss in men.